Published in Cancer Res on September 09, 2015
Cancer-associated Fibroblasts Promote Irradiated Cancer Cell Recovery Through Autophagy. EBioMedicine (2017) 0.83
Disseminated tumor cells and dormancy in prostate cancer metastasis. Curr Opin Biotechnol (2016) 0.78
FXR1a-associated microRNP: a driver of specialized non-canonical translation in quiescent conditions. RNA Biol (2016) 0.75
GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism. Cytokine Growth Factor Rev (2016) 0.75
Elucidation of molecular and functional heterogeneity through differential expression network analyses of discrete tumor subsets. Sci Rep (2016) 0.75
Drug Resistance to EGFR Inhibitors in Lung Cancer. Chemotherapy (2016) 0.75
Molecular portraits of human breast tumours. Nature (2000) 94.14
Targeting HIF-1 for cancer therapy. Nat Rev Cancer (2003) 28.01
CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev (1999) 24.83
A molecular signature of metastasis in primary solid tumors. Nat Genet (2002) 21.36
In vivo cancer targeting and imaging with semiconductor quantum dots. Nat Biotechnol (2004) 17.47
Triple-negative breast cancer: clinical features and patterns of recurrence. Clin Cancer Res (2007) 16.79
A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell (2010) 11.20
Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol (1997) 10.61
Immunosuppressive networks in the tumour environment and their therapeutic relevance. Nat Rev Cancer (2005) 10.06
Role of angiogenesis in tumor growth and metastasis. Semin Oncol (2002) 9.77
The immunobiology of cancer immunosurveillance and immunoediting. Immunity (2004) 9.39
Adaptive immunity maintains occult cancer in an equilibrium state. Nature (2007) 8.14
Detection, clinical relevance and specific biological properties of disseminating tumour cells. Nat Rev Cancer (2008) 7.99
Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med (1995) 7.37
Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell (2011) 7.30
Models, mechanisms and clinical evidence for cancer dormancy. Nat Rev Cancer (2007) 6.58
A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell (2010) 6.47
Dissecting the metastatic cascade. Nat Rev Cancer (2004) 6.32
G1 cell-cycle control and cancer. Nature (2004) 5.72
Tumor angiogenesis. Adv Cancer Res (1985) 5.66
MYC inactivation uncovers pluripotent differentiation and tumour dormancy in hepatocellular cancer. Nature (2004) 5.61
Ki67 in breast cancer: prognostic and predictive potential. Lancet Oncol (2010) 5.25
Cancer incidence before and after kidney transplantation. JAMA (2006) 4.77
The concept of immunological surveillance. Prog Exp Tumor Res (1970) 4.76
Circulating tumor cells in patients with breast cancer dormancy. Clin Cancer Res (2004) 4.48
A model of human tumor dormancy: an angiogenic switch from the nonangiogenic phenotype. J Natl Cancer Inst (2006) 4.44
Conditional activation of Neu in the mammary epithelium of transgenic mice results in reversible pulmonary metastasis. Cancer Cell (2002) 4.36
Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med (2000) 4.36
Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction. Cancer Cell (2004) 4.34
Dormancy of mammary carcinoma after mastectomy. J Natl Cancer Inst (1999) 3.78
The perivascular niche regulates breast tumour dormancy. Nat Cell Biol (2013) 3.36
Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat Med (2004) 2.78
ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK). Cancer Res (2003) 2.75
Integrin beta1-focal adhesion kinase signaling directs the proliferation of metastatic cancer cells disseminated in the lungs. Proc Natl Acad Sci U S A (2009) 2.75
The dormant cancer cell. Br Med J (1954) 2.69
Cancer without disease. Nature (2004) 2.65
Inhibition of metastatic outgrowth from single dormant tumor cells by targeting the cytoskeleton. Cancer Res (2008) 2.63
The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Invest (2008) 2.63
Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy. Cancer Res (2002) 2.36
Late recurrence of malignant melanoma. Analysis of 168 patients. Ann Surg (1990) 2.27
Urokinase receptor and fibronectin regulate the ERK(MAPK) to p38(MAPK) activity ratios that determine carcinoma cell proliferation or dormancy in vivo. Mol Biol Cell (2001) 2.21
Does tumour dormancy offer a therapeutic target? Nat Rev Cancer (2010) 2.19
Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells. Cancer Res (2006) 2.15
Ineffectiveness of doxorubicin treatment on solitary dormant mammary carcinoma cells or late-developing metastases. Breast Cancer Res Treat (2003) 2.14
Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res (2005) 2.10
Mechanisms of disseminated cancer cell dormancy: an awakening field. Nat Rev Cancer (2014) 2.09
Immune microenvironments in solid tumors: new targets for therapy. Genes Dev (2011) 2.08
Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res (2010) 1.95
Sustained regression of tumors upon MYC inactivation requires p53 or thrombospondin-1 to reverse the angiogenic switch. Proc Natl Acad Sci U S A (2006) 1.89
Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy. Blood (2013) 1.89
Green fluorescent protein tagging of extracellular signal-regulated kinase and p38 pathways reveals novel dynamics of pathway activation during primary and metastatic growth. Cancer Res (2004) 1.84
Mechanisms governing metastatic dormancy and reactivation. Cell (2013) 1.81
Immune-mediated dormancy: an equilibrium with cancer. J Leukoc Biol (2008) 1.75
Ultra-late recurrence (15 years or longer) of cutaneous melanoma. Cancer (1997) 1.71
Controversies in clinical cancer dormancy. Proc Natl Acad Sci U S A (2011) 1.71
An analogy between the evolution of drug resistance in bacterial communities and malignant tissues. Nat Rev Cancer (2011) 1.58
Systemic cancer progression and tumor dormancy: mathematical models meet single cell genomics. Cell Cycle (2006) 1.54
Dormancy of solitary metastatic cells. Cell Cycle (2006) 1.53
Post-transplant malignancy: the role of immunosuppression. Drug Saf (2000) 1.53
Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery. N Engl J Med (2003) 1.53
Asymmetric cancer cell division regulated by AKT. Proc Natl Acad Sci U S A (2011) 1.52
Targeting leukemic stem cells by breaking their dormancy. Mol Oncol (2010) 1.36
Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what? Open Biol (2012) 1.24
β1-integrin: a potential therapeutic target in the battle against cancer recurrence. Clin Cancer Res (2011) 1.23
Malignant melanoma in organ allograft recipients. Transplantation (1996) 1.22
Autophagy-induced tumor dormancy in ovarian cancer. J Clin Invest (2008) 1.16
Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors. Proc Natl Acad Sci U S A (2002) 1.15
The tumor dormant state. Quantitation of L5178Y cells and host immune responses during the establishment and course of dormancy in syngeneic DBA/2 mice. J Exp Med (1979) 1.11
Interruption of tumor dormancy by a transient angiogenic burst within the tumor microenvironment. Proc Natl Acad Sci U S A (2006) 1.08
Cancer dormancy. VII. A regulatory role for CD8+ T cells and IFN-gamma in establishing and maintaining the tumor-dormant state. J Immunol (1999) 1.07
Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer. Br J Cancer (2009) 1.04
Estimate of tumor growth time for breast cancer local recurrences: rapid growth after wake-up? Breast Cancer Res Treat (1998) 0.98
Emergence of antitumor cytolytic T cells is associated with maintenance of hematologic remission in children with acute myeloid leukemia. Blood (2006) 0.97
A novel model of dormancy for bone metastatic breast cancer cells. Cancer Res (2013) 0.93
Late recurrence (10 years or more) of malignant melanoma in south-east Germany (Saxony). A single-centre analysis of 1881 patients with a follow-up of 10 years or more. J Eur Acad Dermatol Venereol (2010) 0.92
Late metastases of cutaneous melanoma: an analysis of 31 patients. J Am Acad Dermatol (2000) 0.91
Advanced donor-origin melanoma in a renal transplant recipient: immunotherapy, cure, and retransplantation. Transplantation (1998) 0.91
Late (> 10 years) recurrence of melanoma: the Scottish experience. Br J Dermatol (2003) 0.89
Survival of leukemic cells in a dormant state following cyclophosphamide-induced cure of strongly immunogenic mouse leukemia (DL811). Int J Cancer (1991) 0.87
A mechanism for asymmetric cell division resulting in proliferative asynchronicity. Mol Cancer Res (2015) 0.86
Dormancy of cancer cells with suppression of AKT activity contributes to survival in chronic hypoxia. PLoS One (2014) 0.85
Remission of transplanted melanoma--clinical course and tumour cell characterisation. Clin Transplant (1997) 0.85
Brain metastases from breast cancer: lessons from experimental magnetic resonance imaging studies and clinical implications. J Mol Med (Berl) (2013) 0.83
What can be learnt about disease progression in breast cancer dormancy from relapse data? PLoS One (2013) 0.80
[The long-term prognosis of breast cancer. Retrospective study of 973 patients]. Langenbecks Arch Chir (1992) 0.76
A mechanism for asymmetric cell division resulting in proliferative asynchronicity. Mol Cancer Res (2015) 0.86